Enterosorbents in the complex therapy of CKD in pediatric patients

Authors

  • Miroshnichenko A.V School of Medicine intern, NCJSC “Karaganda Medical University”
  • Kunz E.A. clinical mentor of residents of the Department of Pediatrics and Neonatology, NCJSC “Karaganda Medical University”
  • Zhupenova D.E. Candidate of Medical Sciences, Professor of the Department of Pediatrics and Neonatology, NCJSC “Karaganda Medical University”

Keywords:

chronic kidney disease, enterosorption, polysorb, treatment

Abstract

The presented study assessed the effectiveness of enterosorption in the complex therapy of chronic kidney disease in children. Patients aged 10 to 18 years with a diagnosed CKD of 2-4 degrees were randomized into 2 groups - a therapy group using Polysorb - 19 patients, and a group of standard enterosorbents (activated carbon, tagansorbent) - 19 patients. The effectiveness of enterosorption was assessed based on the dynamics of glomerular filtration rate (GFR) during 9 months of treatment in a hospital and outpatient setting. The data was processed statistically. The results obtained allow us to judge a greater rate of increase in GFR in the group using the Polysorb drug compared to standard sorbents

Published

2024-07-15

How to Cite

Miroshnichenko A.V, Kunz E.A., & Zhupenova D.E. (2024). Enterosorbents in the complex therapy of CKD in pediatric patients. Theoretical Hypotheses and Empirical Results, (7). Retrieved from https://ojs.scipub.de/index.php/THIR/article/view/3960

Issue

No. 7 (2024): Theoretical Hypotheses and Empirical Results

Section

Medical Sciences

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.